AbCellera to Participate at Upcoming Investor Conferences in November and December 2025
businesswire.com
ABCL
AbCellera (ABCL) is mentioned in the context of investor conferences and company updates, but the information provided does not indicate a clear bullish or bearish sentiment.
ABCL
AbCellera (ABCL) is mentioned in the context of investor conferences and company updates, but the information provided does not indicate a clear bullish or bearish sentiment.
VANCOUVER, British Columbia--( BUSINESS WIRE)-- AbCellera (Nasdaq: ABCL) today announced that the Company will participate in the following investor conferences:
Visit AbCellera's Investor Relations website for additional information.
About AbCellera Biologics Inc.
AbCellera (Nasdaq: ABCL) is a clinical-stage biotechnology company focused on discovering and developing antibody-based medicines in the areas of endocrinology, women’s health, immunology, and oncology. For more information, please visit www.abcellera.com.